Cargando…
Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review
Sarcomatoid carcinoma is a rare malignancy characterized by a combination of epithelial and sarcoma or sarcoma-like components. In this study, we reported one case of pulmonary sarcomatoid carcinoma and evaluated the safety and efficacy of apatinib, a tyrosine kinase inhibitor selectively targeting...
Autores principales: | Li, Xiaofeng, He, Yueming, Zhu, Jinfeng, Pang, Hongxia, Lin, Yongwei, Zheng, Jinyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154744/ https://www.ncbi.nlm.nih.gov/pubmed/30263099 http://dx.doi.org/10.18632/oncotarget.25989 |
Ejemplares similares
-
First-line albumin-bound paclitaxel/carboplatin plus apatinib in advanced pulmonary sarcomatoid carcinoma: A case series and review of the literature
por: Kong, Feng-Wei, et al.
Publicado: (2020) -
Immunophenotyping of pulmonary sarcomatoid carcinoma
por: Ma, Yu, et al.
Publicado: (2022) -
Clinical analysis of 78 pulmonary sarcomatoid carcinomas with
surgical treatment
por: Gong, Ting, et al.
Publicado: (2022) -
Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre
por: Bondili, Suresh Kumar, et al.
Publicado: (2022) -
Sarcomatoid Carcinoma Mimicking Malignant Mesothelioma
por: Takiguchi, Junji, et al.
Publicado: (2017)